![David Berry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Berry
Keine laufenden Positionen mehr
Profil
David A. Berry founded LS Dissolution, Inc. in 2005, Indigo Ag, Inc. in 2013, Omega Therapeutics, Inc. in 2017, where he worked as CEO & Board Member, and various other companies.
Dr. Berry also founded T2 Biosystems, Inc., Decacorn LLC, and Valo Health, Inc., where he worked as Chief Executive Officer & Director.
Dr. Berry also currently works at Averin Capital Acquisition Corp., as Chairman & Chief Executive Officer from 2025, Osler Diagnostics Ltd., as Non-Executive Director from 2022, Oaktree Acquisition Corp.
III Life Sciences, as Independent Director from 2025, and various other companies.
Dr. Berry also formerly worked at Senda Biosciences, Inc., as Chairman, Avedro, Inc., as Director from 2013 to 2015, Cogen Immune Medicine, Inc., as Director, and various other companies.
Dr. Berry received his doctorate degree in 2005 from Massachusetts Institute of Technology, undergraduate degree in 2000 from Massachusetts Institute of Technology, and graduate degree in 2006 from Harvard Medical School.
Aktive Positionen von David Berry
| Unternehmen | Position | Beginn |
|---|---|---|
Epiva Biosciences, Inc.
 Epiva Biosciences, Inc. BiotechnologyHealth Technology Develops immunobiotic therapeutics | Präsident | - |
United Nations Sustainable Development Solutions Network | Corporate Officer/Principal | - |
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Corporate Officer/Principal | - |
Osler Diagnostics Ltd.
 Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 21.03.2022 |
Longevity Vision Fund
 Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund invests in companies located in the United States. The firm targets companies operating in the fields of health technologies, longevity, biotech and artificial intelligence in healthcare. It provides financing for early and late stage capital requirements. | Berater | - |
Hackley School, Inc.
 Hackley School, Inc. Other Consumer ServicesConsumer Services Operates school | Berater | 01.01.2019 |
Biolinq, Inc.
 Biolinq, Inc. Electronic Production EquipmentElectronic Technology Develops electrochemical sensor and biosensor paradigms | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von David Berry
| Unternehmen | Position | Ende |
|---|---|---|
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Gründer | 16.01.2024 |
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Vorstandsvorsitzender | 16.01.2024 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von David Berry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
33
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 33 |
|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Avedro, Inc.
 Avedro, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic pharmaceuticals & medical devices | Health Technology |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and biotechnology chemicals | Health Technology |
Boston Philharmonic Orchestra
 Boston Philharmonic Orchestra Movies/EntertainmentConsumer Services Operates as a semi-professional orchestra | Consumer Services |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries Produces petroleum replacement products and industrial chemicals | Process Industries |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Produces renewable fuels, gases and chemicals | Process Industries |
Hackley School, Inc.
Hackley School, Inc. Other Consumer ServicesConsumer Services Operates school | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Theracrine, Inc.
 Theracrine, Inc. BiotechnologyHealth Technology Develops anti-metastatic drugs for cancer therapeutics | Health Technology |
Essentient, Inc.
 Essentient, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transforming global nutrition | Commercial Services |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Develops biological and digital technologies | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Biolinq, Inc.
Biolinq, Inc. Electronic Production EquipmentElectronic Technology Develops electrochemical sensor and biosensor paradigms | Electronic Technology |
Epiva Biosciences, Inc.
Epiva Biosciences, Inc. BiotechnologyHealth Technology Develops immunobiotic therapeutics | Health Technology |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company | Commercial Services |
Osler Diagnostics Ltd.
Osler Diagnostics Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Inari Agriculture, Inc.
 Inari Agriculture, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops seeds | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Longevity Vision Fund
Longevity Vision Fund Investment ManagersFinance Longevity Vision Fund invests in companies located in the United States. The firm targets companies operating in the fields of health technologies, longevity, biotech and artificial intelligence in healthcare. It provides financing for early and late stage capital requirements. | Finance |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Decacorn LLC
 Decacorn LLC Miscellaneous Commercial ServicesCommercial Services Provides business development data and research company for lawyers | Commercial Services |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Technology Services |
United Nations Sustainable Development Solutions Network | |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
